Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Pharma Guide

Delpharm Consultants Pty Limited

Delpharm Consultants is one of Australia's leading independent consultancies focusing on pharmaceutical development and related regulatory issues.

Since 1994 we have been providing high quality consultancy and impartial advice to members of the pharmaceutical and biotechnology industries, including advice in areas such as:


Clinical Trial Design and Management;
Regulatory Management Services;
Commercialisation;
GCP Compliance Audits; and
Data Reduction and Final Reports.

Our experienced consultants have held senior positions in the pharmaceutical industry and have considerable expertise in the areas of contract and academic research.

Address: Suites 211 & 212, 5 Alexander St
State: NSW
Suburb: Crows Nest
Postcode: 2065

Phone: (02) 9966-8622
Fax: (02) 9966-9244
Email: delphar@bigpond.net.au
Web address: www.delpharm.com.au

Pipeline Monitor
New RA drug in view
A new rheumatoid arthritis drug from Sanofi and more good news for MSD on blockbuster Keytruda were highlights among pipeline decisions this week.
Perspective
MSD v PBAC: it's all about the data
It might have been short but MSD's statement on the revised draft report of the post-market review of ezetimibe spoke volumes on how treatment of PBS data can skew conclusions to potentially alarming effect.
Approvals Action
New hope for metabolic disease
Alexion's orphan therapy Kanuma has been approved by the TGA for metabolic disease lysomal acid lipase deficiency.